Ketorolac Tromethamine Injection, Solution
Product Images NDC 51662-1669

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Ketorolac Tromethamine (NDC 51662-1669). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (0409 3796 25 Ketorolac Tromethamine Vial Image)

KETOROLAC TROMETHAMINE 60 mg/2 mL injection solution in a 2 mL single-dose amber glass vial with a purple cap. The label indicates the product is for intramuscular use only and is distributed by Hospira, Inc., Lake Forest, IL, USA.*

FDA Label Image

Table (51662 1669 Table 1)

A table presenting approximate average pharmacokinetic parameters (Mean±SD) for oral, intramuscular, and intravenous doses of ketorolac tromethamine. It includes data on bioavailability, peak plasma concentration times (Tmax), peak plasma concentrations (Cmax), steady-state concentrations (Cmin and Cmax at steady state), volume of distribution (Vd), and percent dose metabolized and excreted. The table covers doses from 10 mg to 60 mg and notes sample sizes and data derivation specifics.*

FDA Label Image

Table (51662 1669 Table 3)

A data table listing gastrointestinal (GI) experiences and other adverse experiences associated with a drug. GI experiences include symptoms like abdominal pain, constipation/diarrhea, dyspepsia, flatulence, GI fullness, GI ulcers, heartburn, nausea, stomatitis, and vomiting. Other experiences listed are abnormal renal function, anemia, dizziness, drowsiness, edema, elevated liver enzymes, headaches, hypertension, increased bleeding time, injection site pain, pruritus, purpura, rashes, tinnitus, and sweating. A footnote indicates that incidences marked with an asterisk occur at a rate greater than 10%.*

FDA Label Image

Structure (51662 1669 Structure)

Chemical structure of Ketorolac Tromethamine showing the molecular formula with C15H13NO3 and C4H11NO3 components.*

FDA Label Image

Table (51662 1669 Table 2)

A data table titled 'The Influence of Age, Liver and Kidney Function, on the Clearance and Terminal Half-life of Ketorolac Tromethamine (Intramuscular and Oral) in Adult Populations.' The table compares total clearance (L/h/kg) and terminal half-life (hours) of Ketorolac Tromethamine by intramuscular and oral routes across different subject types: normal subjects, healthy elderly subjects, patients with hepatic dysfunction, patients with renal impairment, and renal dialysis patients. Mean values and ranges are provided for each group in both clearance and half-life measurements.*

FDA Label Image

Table (51662 1669 Table 4)

A data table showing the incidence of clinically serious gastrointestinal bleeding related to age, total daily dose, and history of gastrointestinal perforation, ulcer, or bleeding (PUB) after up to 5 days of treatment with Ketorolac Tromethamine Injection. The table is divided into two sections: adult patients without history of PUB and adult patients with history of PUB, with incidence percentages presented for different age groups and dosage ranges.*

FDA Label Image

Label (51662 1669 1 Vial Label)

Label showing serialized information and a QR code for KETOROLAC TROMETHAMINE injection distributed by HF Acquisition Co LLC, Mukilteo, WA. The label includes instructions to see the manufacturer's insert and states 'RX ONLY.' No dosage or strength details are visible on this part of the label.*

FDA Label Image

Label (51662 1669 2 Pouch Label)

Label for Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL) solution in a 2 mL vial. The label includes the NDC number 51662-1669-2, lot number 789210, and expiration date 2023-09-19. It notes the product is for intramuscular use only and is distributed by HF Acquisition Co LLC in Mukilteo, WA.*

FDA Label Image

Label (51662 1669 3 Box Label)

Label for KETOROLAC TROMETHAMINE injection, USP, 60 mg/2 mL (30 mg/mL) solution in a 2 mL vial, box of 25. The label includes NDC 51662-1669, lot number 789210, and expiration date 2023-09-19. It states intramuscular use and contains information on contents and storage. Distributed by HF Acquisition Co LLC, Mukilteo, WA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.